Most recently, Viel et al. have shown that TGFβ1 signaling in both murine and human NK cells inhibits their activation by repressing the mTOR pathway and that deletion of TGFβRII on NK cells restores mTOR signaling and promotes their ability to limit metastasis in multiple murine tumor models [135]. The gene discussed is MTOR; the disease is neoplasm.